Nano-particulate Toll-like Receptor 9 Agonist Potentiates the Antitumor Activity of Anti-Glypican-1 Antibody.
Saito Y, Takahashi T, Hiramatsu K, Serada S, Fujimoto M, Ohkawara T, Sugase T, Nishigaki T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Nakajima K, Yamasaki M, Ishii KJ, Eguchi H, Doki Y, Naka T.
Saito Y, et al. Among authors: ohkawara t.
Anticancer Res. 2023 Jun;43(6):2425-2432. doi: 10.21873/anticanres.16410.
Anticancer Res. 2023.
PMID: 37247902